Second Primary Malignancy after Acute Promyelocytic Leukemia: A Population-Based Study

SIMPLE SUMMARY: Acute promyelocytic leukemia (APL) is a rare and aggressive subtype of acute myeloid leukemia (AML). Since the introduction of all-trans-retinoic acid (ATRA) in APL management, the survival rate has increased substantially. However, there is evidence that retinoids might enhance tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenzi, Luana, Lee-Jones, Lisa, Mostofa, Maruf A., de Andrade, Diancarlos P., Ribeiro, Raul C., Figueiredo, Bonald C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761603/
https://www.ncbi.nlm.nih.gov/pubmed/33287098
http://dx.doi.org/10.3390/cancers12123610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761603/
https://www.ncbi.nlm.nih.gov/pubmed/33287098
http://dx.doi.org/10.3390/cancers12123610

Ejemplares similares